Fecal microbiota transplantation for ulcerative colitis

Fecal microbiota transplantation for ulcerative colitis

Altered abundance and composition of the gut microbiota, i.e., dysbiosis, is reported to be involved in the pathogenesis of various diseases including not only gastrointestinal diseases but also metabolic, neurological, and autoimmune disorders. Fecal microbiota transplantation (FMT) aims to correct...

Full description

Bibliographic Details
Main Author:	Katsuyoshi Matsuoka
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	Immunological Medicine
Subjects:	ulcerative colitis dysbiosis fecal microbiota transplantation gut microbiota
Online Access:	http://dx.doi.org/10.1080/25785826.2020.1792040

Similar Items

Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
by: Shinta Mizuno, et al.
Published: (2017-01-01)

Fecal microbiota transplantation for recurrent infection in a patient with ulcerative colitis
by: Kosaku Nanki, et al.
Published: (2018-01-01)

Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: A randomized clinical trial
by: Sergii Tkach, et al.
Published: (2023-01-01)

The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation
by: Ruiqiao He, et al.
Published: (2022-12-01)

Incidental benefits after fecal microbiota transplant for ulcerative colitis
by: Ramit Mahajan, et al.
Published: (2020-07-01)

Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation
by: Hao-Ming Xu, et al.
Published: (2021-04-01)

Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative Colitis
by: Xiaochen Zhang, et al.
Published: (2022-02-01)

Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance
by: Chunlan Huang, et al.
Published: (2022-06-01)

Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews
by: Haixia Liu, et al.
Published: (2023-11-01)

Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study
by: Avnish Kumar Seth, et al.
Published: (2022-04-01)

Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
by: A. Y. Tikunov, et al.
Published: (2020-04-01)

The Impacts of Fecal Microbiota Transplantation from Same Sex on the Symptoms of Ulcerative Colitis Patients
by: Shang Shu, et al.
Published: (2023-09-01)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
by: Chunlan Huang, et al.
Published: (2022-08-01)

Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study
by: Yan Tian, et al.
Published: (2019-07-01)

Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation
by: Qiongyun Chen, et al.
Published: (2023-06-01)

Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series
by: Xiao-Fei Dang, et al.
Published: (2020-11-01)

Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations
by: Andrea Quagliariello, et al.
Published: (2020-09-01)

Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis
by: Qiongyun Chen, et al.
Published: (2023-01-01)

Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study
by: Haiming Fang, et al.
Published: (2021-01-01)

The Effects of Multi-Donor Fecal Microbiota Transplantation Capsules Combined with Thalidomide on Hormone-Dependent Ulcerative Colitis
by: Guo XH, et al.
Published: (2022-12-01)

Case report: Fecal microbiota transplantation in refractory ankylosing spondylitis
by: Lei Wang, et al.
Published: (2023-02-01)

Fecal microbiota transplantation augmented by a sulfide‐reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis
by: Robert V Bryant, et al.
Published: (2021-09-01)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
by: Loris Riccardo Lopetuso, et al.
Published: (2023-10-01)

Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation
by: Koki Okahara, et al.
Published: (2020-05-01)

Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis by Downregulating Pro-inflammatory Cytokines in Mucosa and Serum
by: Wen-Hui Zhang, et al.
Published: (2022-04-01)

Sterile Fecal Microbiota Transplantation Boosts Anti-Inflammatory T-Cell Response in Ulcerative Colitis Patients
by: Anton Chechushkov, et al.
Published: (2024-02-01)

The efficacy of fecal microbiota transplantation for patients with chronic pouchitis: A case series
by: Atsushi Nishida, et al.
Published: (2019-04-01)

Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
by: Ajit Sood, et al.
Published: (2019-01-01)

An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis
by: Manuel Ponce-Alonso, et al.
Published: (2021-06-01)

Utility of autologous fecal microbiota transplantation and elucidation of microbiota in diversion colitis
by: Kentaro Tominaga, et al.
Published: (2022-04-01)

Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes
by: Mèlanie V. Bénard, et al.
Published: (2023-09-01)

Ischemic colitis complicated by infection treated with fecal microbiota transplantation
by: Seok Hyung Kang, et al.
Published: (2023-09-01)

Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation
by: Artem Y. Tikunov, et al.
Published: (2023-12-01)

Long term management of ulcerative colitis with Faecal Microbiota Transplantation
by: Arshdeep Singh, et al.
Published: (2020-12-01)

Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells
by: Zitao Wang, et al.
Published: (2019-11-01)

Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection
by: Hayato Osaki, et al.
Published: (2021-08-01)

Efficacy and safety of fecal microbiota transplantation for chronic insomnia in adults: a real world study
by: Haiming Fang, et al.
Published: (2023-11-01)

Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges
by: Arndt Steube, et al.
Published: (2023-03-01)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
by: Chang Mo Moon, et al.
Published: (2021-03-01)

Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches
by: Jana Štofilová, et al.
Published: (2022-09-01)